Immunotherapeutics

Immunotherapeutics, Volume 129, highlights new advances in the field, including vaccines, lung-targeted RNA-based therapeutics, clostridium difficile, antivenoms, natural killer cell-based strategies, and immunological insights.

Format: Hardback
Length: 492 pages
Publication date: 11 March 2022
Publisher: Elsevier Science & Technology

The 129th volume in the Advances in Protein Chemistry and Structural Biology series, titled "Immunotherapeutics," showcases groundbreaking developments in this field. This latest edition presents a captivating collection of chapters covering diverse topics such as:

Vaccines for the Prevention and Treatment of HPV: This chapter explores the role of vaccines in safeguarding against human papillomavirus (HPV) infections and their potential in treating associated conditions.

Lung-Targeted RNA-Based Therapeutics: This chapter delves into the use of RNA-based therapeutics for the treatment of lung diseases, highlighting their effectiveness in delivering therapeutic agents specifically to the lung tissue.

Clostridium difficile: Current Overview and Future Perspectives: This chapter provides an in-depth analysis of Clostridium difficile, a leading cause of antibiotic-associated diarrhea, and explores potential strategies for its prevention and treatment.

Antivenoms for Treatment of Snake Bites: This chapter discusses the development and use of antivenoms to treat snake bites, emphasizing their role in preventing venom-induced complications and saving lives.

Natural Killer Cell-Based Strategies for Immunotherapy of Cancer: This chapter explores the use of natural killer cells as a powerful tool in cancer immunotherapy, highlighting their ability to target and destroy cancer cells.

Immunological Insights of Selectins in Human Disease Mechanism: This chapter explores the role of selectins in human disease, particularly in inflammation and immune responses, and sheds light on their potential as therapeutic targets.

Current Update, Challenges, and Future Aspects of Immunotherapeutics in Non-Small Cell Lung Cancer: This chapter provides an up-to-date overview of immunotherapeutics in non-small cell lung cancer, discussing their effectiveness, challenges, and future prospects.

In Silico Interaction Analysis of NEMO Binding Domain Peptide on the NFkB Protein: This chapter explores the in silico interaction analysis of the NEMO binding domain peptide on the NFkB protein, shedding light on the potential mechanisms of NFkB regulation in immune responses.

And much more!

This comprehensive volume offers valuable insights into the latest advancements in immunotherapeutics, providing researchers, clinicians, and healthcare professionals with a valuable resource for understanding and developing innovative treatments for a wide range of diseases.

Weight: 880g
Dimension: 161 x 238 x 31 (mm)
ISBN-13: 9780323992275